Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other analysts have also issued reports on ALLO. Oppenheimer initiated coverage on shares of Allogene Therapeutics in a research note on Thursday, August 8th. […]
More Stories
Espey Mfg. & Electronics Corp. (NYSEAMERICAN:ESP) Short Interest Up 57.1% in October
Espey Mfg. & Electronics Corp. (NYSEAMERICAN:ESP – Get Free Report) was the recipient of a large increase in short interest...
Short Interest in CTO Realty Growth, Inc. (NYSE:CTO) Increases By 56.1%
CTO Realty Growth, Inc. (NYSE:CTO – Get Free Report) saw a large increase in short interest during the month of...
Hafnia Limited (NYSE:HAFN) Short Interest Up 58.7% in October
Hafnia Limited (NYSE:HAFN – Get Free Report) was the target of a significant increase in short interest during the month...
Salzgitter AG (OTCMKTS:SZGPY) Short Interest Update
Salzgitter AG (OTCMKTS:SZGPY – Get Free Report) was the recipient of a large increase in short interest during the month...
Short Interest in Telenor ASA (OTCMKTS:TELNF) Declines By 34.8%
Telenor ASA (OTCMKTS:TELNF – Get Free Report) was the target of a large decrease in short interest in the month...
DeepMarkit (CVE:MKT) Hits New 1-Year Low – Here’s Why
DeepMarkit Corp. (CVE:MKT – Get Free Report) shares reached a new 52-week low during trading on Tuesday . The company...